• February 5, 2018

    Ex-Doc Gets 8 Years For Fraud, Illegally Dispensing Opioids

    A former Kentucky doctor will serve eight years in prison after pleading guilty to nearly 50 charges of illegal distribution of opioids and health care fraud, the U.S. Department of Justice said Monday.

  • February 5, 2018

    Ex-USA Gymnastics Doc Gets 40 To 125 More Years In Prison

    A Michigan state judge on Monday sentenced former USA Gymnastics national team doctor Larry Nassar to 40 to 125 years in prison related to his guilty plea on multiple sexual abuse charges, tacking on even more time to the 40 to 175 years he's already been given for various acts committed against young female gymnasts.

  • February 5, 2018

    Navajo Nation Sues HHS Over $7.2M Education Program Cut

    The Navajo Nation sued the U.S. Department of Health and Human Services in D.C. federal court Friday, claiming the agency didn’t give the tribe a chance to challenge a $7.2 million cut in funding for early childhood education.

  • February 5, 2018

    Chiropractors Fight State Farm Bid To End Payments Suit

    Coastal Wellness Centers Inc. and Total Health Chiropractic LLC urged a Florida federal court on Friday not to dismiss their class action alleging State Farm Mutual Automobile Insurance Co. systematically underpaid for certain procedure reimbursements by 2 percent, one of many similar suits pending against a variety of insurers.

  • February 5, 2018

    IRS Asks Supreme Court To Skip Appeal In Marijuana Case

    The IRS on Friday defended its authority to deny tax credits to drug traffickers and urged the U.S. Supreme Court to deny an appeal by a Colorado marijuana company that argued the IRS lacks the power to investigate drug cases.

  • February 2, 2018

    Trump Admin. Greenlights Ind. Medicaid Work Mandate

    The Trump administration on Friday authorized work requirements in Indiana’s Medicaid program, likely inviting new litigation over the move’s impact on low-income Americans.

  • February 2, 2018

    Biomed Co. Appealed Too Late In Trade Secrets Row: 7th Circ.

    German bone cement manufacturer Heraeus Kulzer GmbH was dealt a blow by the Seventh Circuit on Thursday, which ruled the company had not appealed in a timely fashion in relation to a trade secrets dispute with competitor Biomet Inc. 

  • February 2, 2018

    Mass. Health Boards Raise Concerns Over Potential Pipelines

    Dozens of Massachusetts health boards pressed Gov. Charlie Baker on Friday to evaluate the impact that any new hydraulic fracturing gas infrastructure in the state would have not just on the environment but on human health.

  • February 2, 2018

    EEOC Tallies More Than $400K In Settlements

    The U.S. Equal Employment Opportunity Commission revealed more than $400,000 in deals this week ending suits alleging an XPO Logistics unit, a senior living chain, a water and wastewater service company, and others discriminated against workers.

  • February 2, 2018

    2nd Circ. Affirms Dismissal Of Dr. Scholl's Class Action

    A retail business owner seeking to represent a class of Bayer AG customers failed to show that the company’s marketing of its “custom fit” Dr. Scholl’s shoe inserts was likely to mislead reasonable customers, the Second Circuit has said, affirming the case’s dismissal.

  • February 2, 2018

    UNC, Duke Med Faculty Get Cert. In No-Hire Antitrust Suit

    A North Carolina federal judge on Thursday certified a class of faculty from the University of North Carolina medical school and Duke University in a lawsuit over allegedly anti-competitive no-hire arrangements, but said nonfaculty cannot be included due to a risk of “substantial confusion” at trial.

  • February 2, 2018

    UK Health-Tech Co. Closes $28M Series A Funding Round

    U.K.-based health-tech company Medopad has closed a Series A funding round at $28 million with contributions from investors including Chinese conglomerate NWS Holdings Ltd., the company said Friday.

  • February 1, 2018

    Ex-Lab Execs Found Liable For $17M Medicare Fraud

    A medical testing laboratory’s former head and two others committed $17 million worth of Medicare fraud, a South Carolina federal jury found Wednesday, according to prosecutors who also said the verdict in the whistleblower suit will be automatically trebled to $51.2 million.

  • February 1, 2018

    Nurse Gets $100M In Medical Helicopter Crash Suit Deal

    A flight nurse severely burned in a 2015 Colorado medical helicopter crash has reached a $100 million settlement with helicopter manufacturer Airbus Helicopters and medical transporter Air Methods Corp. over claims that the companies had made the helicopter unsafe.

  • February 1, 2018

    Gov't Defends FCA Whistleblower Provision At 10th Circ.

    The whistleblower provision of the False Claims Act isn’t unconstitutional, the Trump administration said Tuesday after intervening to defend the law in a fraudulent health care reimbursement suit pending before the Tenth Circuit.

  • February 1, 2018

    Nurse Who Left Job Can't Get Unemployment Pay: NJ Justices

    The New Jersey Supreme Court on Thursday narrowly ruled that an unemployment compensation law amendment allowing for people who left their jobs for better ones to receive benefits doesn’t apply retroactively, dealing a blow to a nurse who filed her unsuccessful claim before the change was enacted.

  • February 1, 2018

    Inside The Opioid MDL's Big Closed-Door Hearing

    Attorneys for local governments and drug companies traded divergent views of the opioid crisis this week at a closed-door hearing about settlement prospects in a colossal legal fight, sources told Law360.

  • February 1, 2018

    Fresenius To Pay $3.5M After Quintet Of HIPAA Breaches

    Fresenius Medical Care will pay $3.5 million to settle alleged violations of the Health Insurance Portability and Accountability Act’s privacy rules stemming from five separate incidents where electronics containing sensitive health information were stolen or disappeared, the U.S. Department of Health and Human Services said Thursday.

  • February 1, 2018

    5th Circ. Won’t Interfere With Opioid Probe Into Texas Doc

    The Fifth Circuit has rejected a doctor’s attempt to block disciplinary proceedings against him for allegedly overprescribing opioids, ruling Wednesday that he failed to establish bad faith on his interrogators' part, as is required for federal courts to intervene in state civil or criminal prosecutions.

  • February 1, 2018

    5 Challenges For Attys In Doc-Patient Sex Assault Cases

    While bringing a suit against a doctor is rarely an easy task, filing a suit alleging a doctor sexually assaulted a patient carries unique challenges that set the cases apart from the standard medical malpractice case. Here, Law360 looks at the challenges patients and their attorneys must overcome to pursue sexual assault claims against health care providers.

Expert Analysis

  • The Broader Implications Of Sessions’ Marijuana Move

    Markus Funk

    Beyond what it heralds for the marijuana industry, Jeff Sessions’ memo on marijuana enforcement signals a new era of increasingly decentralized federal prosecutorial power, say attorneys with Perkins Coie LLP, including former Colorado Chief Justice Michael Bender.

  • Litigation Finance Trends To Watch In 2018

    Jay Greenberg

    Jay Greenberg and Max Volsky, co-founders of litigation finance platform LexShares Inc., analyze emerging trends based on conversations with their investors and executives in this rapidly evolving sector.

  • 5 Health Care Policy Issues To Follow In 2018

    Pari Mody

    As the 115th Congress enters its second session, it's expected that health care policy will remain at the forefront. Pari Mody and Kristine Blackwood of Arnold & Porter Kaye Scholer LLP discuss the top five health care policy issues to track this year.

  • The Enneagram And The Practice Of Law

    Jennifer Gibbs

    Study of the Enneagram personality typing system can provide attorneys with better insights into themselves, and into those they interact with professionally, including clients, opposing counsel and judges, says Jennifer Gibbs of Zelle LLP.

  • When Gov't Knowledge Of Industry Practice Bars FCA Claims

    Barbara Rowland

    In its recent decision in Spay v. CVS Caremark, the Third Circuit adopted the government knowledge inference defense, thereby offering False Claims Act defendants in the circuit another weapon in their arsenal of defenses to obtain dismissal of FCA claims, say Barbara Rowland and Carolyn Kendall of Post & Schell PC.

  • Massachusetts Marijuana Regulatory Scheme Takes Shape

    Robert Munnelly Jr.

    Massachusetts' emerging regulatory program for both recreational and medical use marijuana, supervised by its new Cannabis Control Commission, will serve as a national model for cannabis industry players and regulators, say Robert Munnelly Jr. and Shawn McCormack of Davis Malm & D'Agostine PC.

  • Series

    Judging A Book: Tymkovich Reviews 'Gorsuch'

    Timothy Tymkovich

    John Greenya’s new book, “Gorsuch: The Judge Who Speaks for Himself,” offers readers something the confirmation hearings did not — the backstory of Neil Gorsuch and a glimpse of who Justice Gorsuch is, says Chief Judge Timothy Tymkovich of the Tenth Circuit.

  • Health Care Boards Face Exceptional Challenges In 2018

    Michael Peregrine

    For health system boards, recent industry developments and the extraordinary transaction activity that occurred at the end of 2017 are harbingers of the challenges ahead, says Michael Peregrine of McDermott Will & Emery.

  • Congressional Forecast: January

    Richard Hertling

    After passage of tax reform legislation, the GOP passed another temporary funding bill to avert a government shutdown before the holidays. As a result, congressional leaders again put off a resolution of a major fiscal debate over the budget, along with partisan disputes over immigration, health care and national security, say Richard Hertling and Kaitlyn McClure of Covington & Burling LLP.

  • 5 Things To Watch For In FCPA Enforcement This Year

    David Simon

    After much hand-wringing in 2017 about whether Foreign Corrupt Practices Act enforcement would diminish radically under President Donald Trump, it’s now safe to say that all signs point toward continued and vigorous enforcement, say attorneys with Foley & Lardner LLP.